That is correct.
Access to COVID-19 convalescent plasma is either by participating in clinical trials or for severe to life threatening cases via single patient emergency investigational new drug application (where FDA approval is required to administer it with strict criteria to access the plasma).
That is correct.Access to COVID-19 convalescent plasma is either...
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.90 |
Change
-0.020(0.01%) |
Mkt cap ! $148.7B | |||
| Open | High | Low | Value | Volume |
| $307.40 | $307.90 | $304.87 | $201.6M | 655.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 863 | $307.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.92 | 211 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |